FDA Approved: GRANISETRON — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for granisetron hydrochloride (granisetron) from Fresenius Kabi USA, LLC, expanding its regulatory authorization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Postoperative Nausea and Vomiting

Drugs mentioned

• Granisetron (granisetron)

Snippet

SUPPL AP for GRANISETRON (GRANISETRON HYDROCHLORIDE)